CHU toulouse - Hôpital Purpan; Departement de Neurologie

Toulouse 31059

0 studies enrolling now · 3 studies all time

What they study most

Huntingtons Disease, Multiple Sclerosis, Relapsing-Remitting, Relapsing Multiple Sclerosis

Studies at this site

• Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) — Stopped early
• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Participants With Manifest Huntington's Disease — Completed